| (JPY) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 233.00M | — |
| Operating expense | — | — |
| Net income | -2.40B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4582.T returned -57.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.8% |
| 1 year | -57.0% |
| 5 years | -94.1% |
| 10 years | -93.4% |
| All-time high | ¥3,356 (Apr 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 4582.T would be worth today ›No. SymBio Pharmaceuticals Limited has not paid a dividend in the past 12 months.
SymBio Pharmaceuticals Limited is part of the Healthcare sector.
SymBio Pharmaceuticals Limited has a market cap of 5.05B JPY, based on the latest quote.
SymBio Pharmaceuticals Limited is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
